Tower Research Capital LLC (Trc) Isoray, Inc. Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	N/A	-8,390 Reduced 43.54%	10,881 $7,000
Q4 2023 Feb 13, 2024	BUY	N/A	5,224 Added 37.19%	19,271 $13,000
Q3 2023 Nov 14, 2023	BUY	N/A	2,824 Added 25.16%	14,047 $9,000
Q2 2023 Aug 14, 2023	BUY	$0.0 - $0.69 $0 - $3,124	4,528 Added 67.63%	11,223 $7,000
Q1 2023 May 09, 2023	SELL	$0.0 - $0.67 $0 - $9,927	-14,817 Reduced 68.88%	6,695 $4,000
Q4 2022 Feb 10, 2023	BUY	$0.24 - $0.4 $5,162 - $8,604	21,512 New	21,512 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.37 $3,586 - $5,104	-13,795 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.31 - $0.41 $1,772 - $2,344	5,718 Added 70.79%	13,795 $5,000
Q4 2021 Feb 14, 2022	BUY	$0.38 - $0.68 $3,069 - $5,492	8,077 New	8,077 $3,000
Q3 2021 Nov 15, 2021	SELL	$0.58 - $0.79 $556 - $758	-960 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.15 $2,600 - $3,987	-3,467 Reduced 78.31%	960 $1,000
Q1 2021 May 17, 2021	SELL	$0.53 - $2.47 $18,866 - $87,927	-35,598 Reduced 88.94%	4,427 $5,000
Q4 2020 Feb 16, 2021	BUY	$0.36 - $0.58 $14,409 - $23,214	40,025 New	40,025 $18,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.